Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3377-3383

  Bouhlal, H ^a   Galon, J ^a   Kazatchkine, M D ^a   Fridman, W H ^a   Sautes Fridman C ^a   Cavaillon, N H ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR5; COMPLEMENT COMPONENT C3 RECEPTOR; FC RECEPTOR; GAG PROTEIN; MONOCLONAL ANTIBODY; RANTES;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE CONTROL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; OPSONIZATION; PRIORITY JOURNAL; VIRUS STRAIN;

EID: 0035284889     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3377     Document Type: Article

References (37)

1. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection
2. The role of monocytes/macrophages and cytokines in the pathogenesis of HIV infection
3. CC CKR-5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
4. The β-chemokine receptors CCR-3 and CCR-5 facilitate infection by primary HIV-1 isolates
5. CCR-5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
6. Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes
7. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4
8. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation
9. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells
10. Complement receptors in HIV infection
11. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-κB (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells
12. Increased CD11/CD18 expression on peripheral blood leukocytes of patients with HIV disease: Relationship to disease severity
13. Structure and function of the leukocyte adhesion molecules CD11/CD18
14. CR3 (CD11b, CD18): A phagocyte and NK cell membrane receptor with multiple ligand specificities and functions
15. Soluble Fcγ receptor type III (FcγRIII, CD16) triggers cell activation through interaction with complement receptors
16. Soluble Fcγ receptor III in human plasma originates from release by neutrophils
17. Identification of the cleavage site of plasma soluble Fcγ receptor type III (CD16)
18. Natural and recombinant soluble low-affinity FcγR: Detection, purification, and functional activities
19. Recombinant soluble FcγR: Production, purification and biological activities
20. Human neutrophil Fcγ receptor distribution and structure
21. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus: Evidence for limited defectiveness and complementation
22. CCR-3 and CCR-5 are co-receptors for HIV-1 infection of microglia
23. Chemokines and HIV-1 second receptors
24. Complement activation by gp160 glycoprotein of HIV-1
25. In vitro analysis of complement-dependent HIV-I cell infection using a model system
26. HIV and human complement: Mechanisms of interaction and biological implication
27. Structure and function of the leukocyte adhesion molecules CD11/CD18
28. Generation of recombinant fragments of CD11b expressing the functional β-glucan-binding lectin site of CR3 (CD11b/CD18)
29. Correlation between serum soluble CD16 (sCD16) levels and disease stage in patients with multiple myeloma
30. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): An accessory role for CR3 during virus entry?
31. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the δ ccr5 mutation
32. Changes of soluble CD16 levels in serum of HIV-infected patients: Correlation with clinical and biologic prognostic factors
33. Immunotherapy of multiple myeloma
34. Neutropenia and bacterial infection in acquired immunodeficiency syndrome
35. Change in expression of FcγRIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals
36. Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura